ASX - By Stock
|
OSL |
Re:
Ann: First patient treated with OncoSil device in Turkiye
|
|
BlingSter
|
8 |
2.2K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
8
|
2.2K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
BlingSter
|
26 |
5.9K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
26
|
5.9K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
BlingSter
|
26 |
5.9K |
2 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
26
|
5.9K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Next price sensitive announcement MSB
|
|
BlingSter
|
41 |
17K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
41
|
17K
|
1
|
|
ASX - By Stock
|
360 |
Re:
Ann: Market Update
|
|
BlingSter
|
46 |
11K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
46
|
11K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
BlingSter
|
567 |
212K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
567
|
212K
|
1
|
|
ASX - By Stock
|
AMP |
Re:
Ann: S&P ratings update
|
|
BlingSter
|
4 |
1.1K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
4
|
1.1K
|
0
|
|
ASX - By Stock
|
AMP |
Re:
What is the aim of the buyback?
|
|
BlingSter
|
99 |
18K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
99
|
18K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
How to Loan out shares on ASX??
|
|
BlingSter
|
30 |
8.6K |
6 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
30
|
8.6K
|
6
|
|
ASX - By Stock
|
AMP |
Re:
What is the aim of the buyback?
|
|
BlingSter
|
99 |
18K |
0 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
99
|
18K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
BlingSter
|
567 |
212K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
567
|
212K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
BlingSter
|
551 |
197K |
8 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
197K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
BlingSter
|
85 |
21K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
85
|
21K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
BlingSter
|
551 |
197K |
13 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
197K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
BlingSter
|
226 |
76K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
76K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Cleansing Notice
|
|
BlingSter
|
3 |
1.8K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
3
|
1.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
BlingSter
|
226 |
76K |
14 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
76K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
FDA meeting
|
|
BlingSter
|
1 |
785 |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
1
|
785
|
4
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
BlingSter
|
58 |
13K |
5 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
58
|
13K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
BlingSter
|
58 |
13K |
2 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
58
|
13K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
171K |
8 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
549
|
171K
|
8
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4D and Half Year Accounts
|
|
BlingSter
|
25 |
7.3K |
1 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
25
|
7.3K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Why OSL is a Multi-Bagger
|
|
BlingSter
|
55 |
21K |
1 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
55
|
21K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
BlingSter
|
154 |
45K |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
45K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
171K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
171K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
171K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
171K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
171K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
549
|
171K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
171K |
5 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
171K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
171K |
7 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
171K
|
7
|
|
ASX - By Stock
|
360 |
Re:
US based equivalent valuation
|
|
BlingSter
|
6 |
3.7K |
4 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
6
|
3.7K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Litigation Update
|
|
BlingSter
|
86 |
33K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
86
|
33K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
BlingSter
|
31 |
9.3K |
8 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
31
|
9.3K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
BlingSter
|
78 |
23K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
23K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2024 Half Year Financial Results Webcast
|
|
BlingSter
|
62 |
22K |
9 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
62
|
22K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2024 Half Year Financial Results Webcast
|
|
BlingSter
|
62 |
22K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
62
|
22K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Why OSL is a Multi-Bagger
|
|
BlingSter
|
55 |
21K |
0 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
55
|
21K
|
0
|
|
ASX - By Stock
|
OSL Biotech |
Re:
Time to go long big on $OSL?
|
|
BlingSter
|
17 |
7.0K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
17
|
7.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.5K |
2.7M |
8 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
9.5K
|
2.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
BlingSter
|
272 |
99K |
8 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
272
|
99K
|
8
|
|
ASX - By Stock
|
AMP |
Re:
Ann: Appendix 4E & 2023 Annual Report
|
|
BlingSter
|
91 |
24K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
91
|
24K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.5K |
2.7M |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
9.5K
|
2.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil - potency assay data
|
|
BlingSter
|
15 |
5.0K |
0 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
15
|
5.0K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.5K |
2.7M |
5 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
9.5K
|
2.7M
|
5
|
|
ASX - By Stock
|
AMP |
Re:
AMP Valuations - up to $2.17
|
|
BlingSter
|
124 |
32K |
0 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
124
|
32K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.5K |
2.7M |
4 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
9.5K
|
2.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.5K |
2.7M |
8 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
9.5K
|
2.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
BlingSter
|
512 |
123K |
2 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
512
|
123K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
BlingSter
|
512 |
123K |
1 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
512
|
123K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
BlingSter
|
512 |
123K |
3 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
512
|
123K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
BlingSter
|
512 |
123K |
6 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
512
|
123K
|
6
|
|